Osteopore Ltd
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates spe… Read more
Osteopore Ltd (OSX) - Total Liabilities
Latest total liabilities as of June 2025: AU$4.62 Million AUD
Based on the latest financial reports, Osteopore Ltd (OSX) has total liabilities worth AU$4.62 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Osteopore Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Osteopore Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Osteopore Ltd Competitors by Total Liabilities
The table below lists competitors of Osteopore Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Reedy Lagoon Corporation Ltd
AU:RLC
|
Australia | AU$686.46K |
|
APPLIED OPTOELECTR
F:A59
|
Germany | €161.55 Million |
|
Core Assets Corp
OTCQB:CCOOF
|
USA | $2.68 Million |
|
Signet International Holdings Inc
PINK:AQPW
|
USA | $387.29K |
|
Baiya International Group Inc. Ordinary Shares
NASDAQ:BIYA
|
USA | $4.40 Million |
|
Yubo International Biotech Limited
PINK:YBGJ
|
USA | $2.56 Million |
|
2U, Inc.
PINK:TWOUQ
|
USA | $1.20 Billion |
|
Kedaung Indah Can Tbk
JK:KICI
|
Indonesia | Rp100.38 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Osteopore Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.59 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -10.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Osteopore Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Osteopore Ltd (2016–2024)
The table below shows the annual total liabilities of Osteopore Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$2.83 Million | -2.82% |
| 2023-12-31 | AU$2.91 Million | +92.30% |
| 2022-12-31 | AU$1.51 Million | +138.97% |
| 2021-12-31 | AU$633.40K | -49.39% |
| 2020-12-31 | AU$1.25 Million | -5.01% |
| 2019-12-31 | AU$1.32 Million | +12.72% |
| 2018-12-31 | AU$1.17 Million | -46.50% |
| 2017-12-31 | AU$2.18 Million | -1.37% |
| 2016-12-31 | AU$2.22 Million | -- |